Our mRNA analysis of the tumor-associated cells in a human HNSCC cohort suggests that endothelial and fibroblast cells express ULBP6/2/5 at minimal to low levels, which may not be sufficient to chronically activate NKG2D. The gene discussed is KLRK1; the disease is neoplasm.